Fifteen start-ups have been awarded Proof-of-Concept (POC) and Proof-of-Value (POV) grants totalling $6 million under SPRING Singapore’s Technology Enterprise Commercialisation Scheme (TECS), which aims to bring potentially disruptive technologies closer to the market.
The 15 projects cover a wide spectrum of technology areas including medical devices, electronics, engineering, water and environment, as well as infocomm.
Among the projects supported are three which could make a notable impact on the healthcare sector when commercialised. One of them, Neurostyle, is developing a new way to teach the brain to ‘rewire’ itself - through virtual reality games - that can help stroke patients recover the movement in their affected limbs. Another start-up, Hexalotus Technology, is coming up with a 3D model that will improve the planning and treatment of liver cancer. Its web-based platform has the added advantage of facilitating consultation and assistance among doctors. T.Ware is developing a therapy system to calm autism patients who can go into uncontrollable fits. Using its T.Jacket which simulates deep pressure massage, a therapist can customise the rhythm and pressure of the ‘hug’ of the jacket according to the patient’s needs. A single therapist can thus attend to many patients at the same time.
Click here to read the full story.
